Castleman's disease pathophysiology: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Castleman's disease}} {{CMG}}; {{AE}} {{RT}} Please help WikiDoc by adding more content here. It's easy! Click here to learn about...")
 
No edit summary
 
Line 10: Line 10:
In all cases, Castleman's disease is likely due to hypersecretion of the cytokine [[Interleukin 6|IL-6]].  In KSHV positive tumors, this is most likely due to expression of the a virus-encoded cytokine, vIL-6, while KSHV negative tumors appear to be the result of over secretion of human IL-6.<ref> Aoki Y, Yarchoan R, Wyvill K, Okamoto S, Little RF, Tosato G. Detection of viral interleukin-6 in Kaposi sarcoma-associated herpesvirus-linked disorders. Blood 2001;97(7):2173-6.</ref>
In all cases, Castleman's disease is likely due to hypersecretion of the cytokine [[Interleukin 6|IL-6]].  In KSHV positive tumors, this is most likely due to expression of the a virus-encoded cytokine, vIL-6, while KSHV negative tumors appear to be the result of over secretion of human IL-6.<ref> Aoki Y, Yarchoan R, Wyvill K, Okamoto S, Little RF, Tosato G. Detection of viral interleukin-6 in Kaposi sarcoma-associated herpesvirus-linked disorders. Blood 2001;97(7):2173-6.</ref>


===Associated Conditions===
Castleman's disease is sometimes associated with:
* [[POEMS syndrome]]
* [[Paraneoplastic pemphigus]]
* [[Thrombotic thrombocytopenic purpura]] ([[TTP]])


==References==
==References==

Latest revision as of 14:12, 21 September 2012

Castleman's disease Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Castleman's disease from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Castleman's disease pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Castleman's disease pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Castleman's disease pathophysiology

CDC on Castleman's disease pathophysiology

Castleman's disease pathophysiology in the news

Blogs on Castleman's disease pathophysiology

Directions to Hospitals Treating Castleman's disease

Risk calculators and risk factors for Castleman's disease pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Overview

Pathophysiology

In all cases, Castleman's disease is likely due to hypersecretion of the cytokine IL-6. In KSHV positive tumors, this is most likely due to expression of the a virus-encoded cytokine, vIL-6, while KSHV negative tumors appear to be the result of over secretion of human IL-6.[1]

Associated Conditions

Castleman's disease is sometimes associated with:

References

  1. Aoki Y, Yarchoan R, Wyvill K, Okamoto S, Little RF, Tosato G. Detection of viral interleukin-6 in Kaposi sarcoma-associated herpesvirus-linked disorders. Blood 2001;97(7):2173-6.

de:Morbus Castleman

Template:WS